ÀÇ·á¹ýÀÎ ÀÌ¿øÀÇ·áÀç´Ü  

ÇмúÀÚ·á

Á¦¸ñ [º¸°Çº¹ÁöºÎ °í½Ã Á¦2020-262È£]¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇס¹ÀϺΰ³Á¤
÷ºÎÆÄÀÏ (2020-262È£_2020.11.24)_¡¸¿ä¾ç±Þ¿©ÀÇ_Àû¿ë±âÁØ_¹×_¹æ¹ý¿¡_°üÇÑ_¼¼ºÎ»çÇס¹_ÀϺΰ³Á¤¾È.hwp (72 KB) ÀÛ¼ºÀÏ 2021-01-06


1. °³Á¤ »çÇ×
   ÇàÀ§ Á¦2Àå °Ë»ç·á Áß
    ¡á ´©321³ªÁÖ2 °©»ó¼±°ü·ÃÇ×ü[Á¤¹Ð¸é¿ª°Ë»ç]-°©»ó¼±Àڱظ鿪±Û·ÎºÒ¸°°Ë»ç[»ý¹°¹ß±¤¹ý]ÀÇ ±Þ¿© ½Å¼³
    ¡á ´©814 Ç×ÇìÆĸ°-PF4Ç×ü IgG[Á¤¹Ð¸é¾ï°Ë»ç] ±Þ¿© ½Å¼³
 

2. °³Á¤³»¿ë


3. °ü·Ã°Ë»ç
   ¡á Thyroid stimulating Ab
   ¡á Anti heparin PF4 IgG


4. ½ÃÇàÀÏ
  
2020³â 12¿ù 1ÀÏ


5. Key point
   ¢º Thyroid stimulating Ab °Ë»ç ±Þ¿© Àüȯ ¹× ¼¼ºÎÀÎÁ¤»çÇ× ½Å¼³
   ¢º Anti heparin PF4 IgG °Ë»ç ±Þ¿© Àüȯ ¹× ¼¼ºÎÀÎÁ¤»çÇ× ½Å¼³